We are live on !
Find out more
XTX Topco Portfolio holdings
AUM
$7.72B
Turnover
39.96%
1-Year Est. Return
32.88%
This Fund
S&P 500
This Quarter Est. Return
+14.41%
1 Year Est. Return
+32.88%
3 Year Est. Return
+87.32%
5 Year Est. Return
+53.71%
10 Year Est. Return
–
AUM
$7.72B
AUM Growth
+$1.97B
(+34%)
Cap. Flow
+$1.58B
Cap. Flow % of AUM
Cap. Flow %
20.47%
Top 10 Holdings %
Top 10 Hldgs %
3.84%
Holding
4,912
New
1,139
Increased
1,694
Reduced
1,253
Closed
824
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$41.2M |
| 2 |
Netflix
NFLX
|
+$35.5M |
| 3 |
Intercontinental Exchange
ICE
|
+$29.7M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$29.4M |
| 5 |
PepsiCo
PEP
|
+$28.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$35.4M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$29.9M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$24.6M |
| 4 |
NVIDIA
NVDA
|
+$23.6M |
| 5 |
Arm
ARM
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.1% |
| 2 | Financials | 15.06% |
| 3 | Industrials | 13.66% |
| 4 | Healthcare | 12% |
| 5 | Consumer Discretionary | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
Orion Office REIT
ONL
$141M
| $78.3K | ﹤0.01% |
27,084
-84,437
| -76% | -$231K |
2025 Q2
4 quarters
|
|
3602
Editas Medicine
EDIT
$418M
| $77.7K | ﹤0.01% |
23,968
-38,468
| -62% | -$112K |
2024 Q3
7 quarters
|
|
3603
OnKure Therapeutics
OKUR
$105M
| $77.4K | ﹤0.01% |
16,970
-17,159
| -50% | -$73.6K |
2025 Q4
2 quarters
|
|
3604
Alpha Teknova
TKNO
$455M
| $77.2K | ﹤0.01% |
+13,599
| New | +$54K |
2026 Q2
0 quarters
|
|
3605
Xerox
XRX
$147M
| $77.1K | ﹤0.01% |
+24,646
| New | +$61.5K |
2026 Q2
0 quarters
|
|
3606
Filana Therapeutics
FLNA
$21.8M
| $76.9K | ﹤0.01% |
64,614
+31,311
| +94% | +$44.6K |
2024 Q4
6 quarters
|
|
3607
Lineage Cell Therapeutics
LCTX
$260M
| $76.5K | ﹤0.01% |
58,365
+25,997
| +80% | +$35.9K |
2025 Q4
2 quarters
|
|
3608
ABVC BioPharma
ABVC
$26.7M
| $76.3K | ﹤0.01% |
+48,276
| New | +$60.1K |
2026 Q2
0 quarters
|
|
3609
Exodus Movement Inc
EXOD
$118M
| $76K | ﹤0.01% |
+14,695
| New | +$102K |
2026 Q2
0 quarters
|
|
3610
NRX Pharmaceuticals
NRXP
$98.3M
| $75.8K | ﹤0.01% |
18,545
-60,188
| -76% | -$199K |
2026 Q1
1 quarter
|
|
3611
TON Strategy Co
TONX
$160M
| $75.6K | ﹤0.01% |
+29,635
| New | +$87.7K |
2026 Q2
0 quarters
|
|
3612
BNY Mellon Strategic Municipals
LEO
$375M
| $75.5K | ﹤0.01% |
+11,684
| New | +$74.5K |
2026 Q2
0 quarters
|
|
3613
Hang Feng Technology Innovation Co
FOFO
$13M
| $75.4K | ﹤0.01% |
+23,713
| New | +$79.3K |
2026 Q2
0 quarters
|
|
3614
Flexible Solutions
FSI
$80.1M
| $74.8K | ﹤0.01% |
11,225
-1,935
| -15% | -$12.1K |
2025 Q4
2 quarters
|
|
3615
Ascent Solar Technologies
ASTI
$17M
| $74.7K | ﹤0.01% |
+14,947
| New | +$80.8K |
2026 Q2
0 quarters
|
|
3616
Townsquare Media
TSQ
$39.8M
| $74.6K | ﹤0.01% |
+10,551
| New | +$68.3K |
2026 Q2
0 quarters
|
|
3617
Franklin Premier Income Trust
PPT
$321M
| $74.5K | ﹤0.01% |
+21,351
| New | +$74.4K |
2026 Q2
0 quarters
|
|
3618
Veritone
VERI
$48.6M
| $74.2K | ﹤0.01% |
+54,142
| New | +$103K |
2026 Q2
0 quarters
|
|
3619
Seer Inc
SEER
$94.1M
| $73.7K | ﹤0.01% |
44,377
+31,227
| +237% | +$56.7K |
2026 Q1
1 quarter
|
|
3620
Janus International
JBI
$682M
| $73.6K | ﹤0.01% |
13,268
-14,688
| -53% | -$77.1K |
2026 Q1
1 quarter
|
|
3621
QTREX Quantum
QTEX
$62.2M
| $73K | ﹤0.01% |
50,676
+429
| +0.9% | +$449 |
2025 Q3
3 quarters
|
|
3622
Quoin Pharmaceuticals
QNRX
$19.3M
| $72.6K | ﹤0.01% |
+15,006
| New | +$81K |
2026 Q2
0 quarters
|
|
3623
Lantern Pharma
LTRN
$8.76M
| $72.6K | ﹤0.01% |
+17,415
| New | +$51.1K |
2026 Q2
0 quarters
|
|
3624
Clarivate
CLVT
$1.49B
| $72.3K | ﹤0.01% |
33,483
-1,695,408
| -98% | -$4.14M |
2025 Q3
3 quarters
|
|
3625
BlackRock Enhanced International Dividend Trust
BGY
$503M
| $72.3K | ﹤0.01% |
12,590
-9,701
| -44% | -$55.4K |
2026 Q1
1 quarter
|
|
Similar funds
XTX Topco's Q2 2026 Portfolio in Review
As of Q2 2026, XTX Topco held 4,912 positions worth $7.72B, up 34% from $5.75B the previous quarter. Its ten largest holdings account for 3.8% of the portfolio.
XTX Topco deployed $1.58B of net new capital in Q2 2026, opening 1,139 new positions and adding to 1,694 existing holdings. Its largest new stake was Netflix: 403,127 shares worth $28.8M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $29.9M trimmed.
- XTX Topco's largest Q2 2026 buy was Netflix: 403,127 shares worth $28.8M.
- XTX Topco added most to Chevron in Q2 2026, an estimated $41.2M increase.
- XTX Topco's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $29.9M.
- XTX Topco fully exited iShares MSCI South Korea ETF in Q2 2026, selling an estimated $35.4M.
- XTX Topco's ten largest holdings make up 3.8% of its $7.72B portfolio in Q2 2026.
- XTX Topco opened 1,139 new positions and closed 824 in Q2 2026.
- XTX Topco's portfolio value rose 34% quarter-over-quarter to $7.72B.
Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.